Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Helicobacter Pylori Treatment Could Minimise Gastric Cancer Risk
1
Mins
July 2024
Researchers have unveiled that Helicobacter pylori treatment may be beneficial for individuals with a high genetic risk to gastric cancer.
Read more
3
Mins
11th September 2017
Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017
Hamburg, Germany, 08 September, 2017 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA)…
3
Mins
30th August 2017
Philips supports global transformation of pathology with two new fully digitized labs in Austria
Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of…
2
Mins
24th August 2017
Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse
Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.
1
Mins
31st July 2017
Colorectal Cancer Risk Reduced by a Mediterranean Diet
RISK of colorectal cancer can be reduced by consuming certain components of the Mediterranean diet, according to data presented at the European…
3
Mins
12th July 2017
Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer
Geneva, Switzerland, 12 July, 2017 – Genomic Health today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed…
4
Mins
11th July 2017
Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data
ASCO recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative breast cancer, to inform decisions on withholding chemotherapy
2
Mins
13th June 2017
PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers
PharmaMar announces encouraging results in clinical trials of Lurbinectedin in endometrial and breast cancers. Find out more
3
Mins
6th June 2017
Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting
Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…
Loading posts...
« Previous
1
…
17
18
19
20
21
…
32
Next »